Emerging studies suggest Retatru tide , a dual stimulator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to offer a promising development for obesity treatment. Initial human tests have indicated substantial reductions in abdominal mass , conceivably